Home The Word Brain Fast Track My Amedeo FAQ About Flying Publisher   

Fast Track

Ear2MemoryFree App | Free PDF | Web
Learning languages on your smartphone

Free Abstracts

  Bladder Cancer

  Free Subscription


1 Am J Transl Res
1 Anticancer Res
1 Biochemistry (Mosc)
1 Biomed Res Int
1 Cancer Res
1 Clin Genitourin Cancer
2 Cytopathology
1 Environ Sci Pollut Res Int
1 Eur Urol
1 Front Med (Lausanne)
1 Genes Environ
1 Georgian Med News
1 Iran J Immunol
2 J Cancer
1 J Urol
1 Lasers Med Sci
1 Mol Med Rep
1 Onco Targets Ther
3 Oncotarget
1 Pathology
2 PLoS One
1 Radiat Oncol
2 Sci Rep
2 Tumour Biol
1 Urol Int
1 Urology
1 Yakugaku Zasshi

  Retrieve available abstracts of this week’s articles:
HTML format
Text format
Single Articles

    Am J Transl Res

  1. YU H, Duan P, Zhu H, Rao D, et al
    miR-613 inhibits bladder cancer proliferation and migration through targeting SphK1.
    Am J Transl Res. 2017;9:1213-1221.
    PubMed     Text format     Abstract available

    Anticancer Res

  2. SILVA J, Arantes-Rodrigues R, Pinto-Leite R, Faustino-Rocha AI, et al
    Synergistic Effect of Carboplatin and Piroxicam on Two Bladder Cancer Cell Lines.
    Anticancer Res. 2017;37:1737-1745.
    PubMed     Text format     Abstract available

    Biochemistry (Mosc)

  3. LI Y, Shan Z, Liu C, Yang D, et al
    MicroRNA-294 Promotes Cellular Proliferation and Motility through the PI3K/AKT and JAK/STAT Pathways by Upregulation of NRAS in Bladder Cancer.
    Biochemistry (Mosc). 2017;82:474-482.
    PubMed     Text format     Abstract available

    Biomed Res Int

  4. CHLOSTA PL, Golabek T, Nyirady P
    New Insights into Diagnosis and Treatment of Renal Cell Carcinoma, Bladder Cancer, and Prostate Cancer.
    Biomed Res Int. 2017;2017:6467072.
    PubMed     Text format    

    Cancer Res

  5. NICHOLSON J, Jevons S, Groselj B, Ellermann S, et al
    E3 ligase cIAP2 mediates downregulation of MRE11 and radiosensitization in response to HDAC inhibition in bladder cancer.
    Cancer Res. 2017 Mar 31. pii: canres.3232.2016.
    PubMed     Text format     Abstract available

    Clin Genitourin Cancer

  6. LEVINE JJ, Somer RA, Hosoya H, Squillante C, et al
    Atezolizumab-induced Encephalitis in Metastatic Bladder Cancer: A Case Report and Review of the Literature.
    Clin Genitourin Cancer. 2017 Mar 16. pii: S1558-7673(17)30063.
    PubMed     Text format    


  7. MIKI Y, Neat M, Chandra A
    Application of The Paris System to atypical urine cytology samples: correlation with histology and UroVysion(R) FISH.
    Cytopathology. 2017;28:88-95.
    PubMed     Text format     Abstract available

  8. LENOS M, Katafigiotis I, Vrettou K, Papaioannou D, et al
    Evaluation of double immunocytochemical staining for CK20 and P53 as a potential adjunct to cytology for urothelial cancer diagnosis.
    Cytopathology. 2017;28:96-102.
    PubMed     Text format     Abstract available

    Environ Sci Pollut Res Int

  9. HINRICHSEN S, Planer-Friedrich B
    Cytotoxic activity of selenosulfate versus selenite in tumor cells depends on cell line and presence of amino acids.
    Environ Sci Pollut Res Int. 2016;23:8349-57.
    PubMed     Text format     Abstract available

    Eur Urol

  10. CHOI W, Ochoa A, McConkey DJ, Aine M, et al
    Genetic Alterations in the Molecular Subtypes of Bladder Cancer: Illustration in the Cancer Genome Atlas Dataset.
    Eur Urol. 2017 Mar 29. pii: S0302-2838(17)30175.
    PubMed     Text format     Abstract available

    Front Med (Lausanne)

  11. KLUMPER N, Syring I, Vogel W, Schmidt D, et al
    Mediator Complex Subunit MED1 Protein Expression Is Decreased during Bladder Cancer Progression.
    Front Med (Lausanne). 2017;4:30.
    PubMed     Text format     Abstract available

    Genes Environ

    New insight for metformin against bladder cancer.
    Genes Environ. 2017;39:13.
    PubMed     Text format     Abstract available

    Georgian Med News

    Georgian Med News. 2016;.
    PubMed     Text format     Abstract available

    Iran J Immunol

  14. FAGHIH Z, Shobeiri SS, Ariafar A, Sarkarian M, et al
    CD8+ T Lymphocyte Subsets in Bladder Tumor Draining Lymph Nodes.
    Iran J Immunol. 2016;13:237-248.
    PubMed     Text format     Abstract available

    J Cancer

  15. LI Y, Guo G, Song J, Cai Z, et al
    B7-H3 Promotes the Migration and Invasion of Human Bladder Cancer Cells via the PI3K/Akt/STAT3 Signaling Pathway.
    J Cancer. 2017;8:816-824.
    PubMed     Text format     Abstract available

  16. WU J, Wan F, Sheng H, Shi G, et al
    NR1H3 Expression is a Prognostic Factor of Overall Survival for Patients with Muscle-Invasive Bladder Cancer.
    J Cancer. 2017;8:852-860.
    PubMed     Text format     Abstract available

    J Urol

  17. KIM JH, Chung BI
    Re: Suppressed Recurrent Bladder Cancer after Androgen Suppression with Androgen Deprivation Therapy or 5alpha-Reductase Inhibitor: M. Shiota, K. Kiyoshima, A. Yokomizo, A. Takeuchi, E. Kashiwagi, T. Dejima, R. Takahashi, J. Inokuchi, K. Tatsugami and
    J Urol. 2017 Mar 29. pii: S0022-5347(17)30226-4. doi: 10.1016/j.juro.2017.
    PubMed     Text format    

    Lasers Med Sci

  18. LUO F, Wang YS, Su YH, Zhang ZH, et al
    Prognostic impact of preoperative anemia on non-muscle-invasive bladder carcinoma treated with GreenLight laser vaporization.
    Lasers Med Sci. 2017;32:397-403.
    PubMed     Text format     Abstract available

    Mol Med Rep

  19. TIAN DW, Hu HL, Sun Y, Tang Y, et al
    Biological effects of eukaryotic recombinant plasmid pReceiver-M61-BAI-1 transfection on T24 cells and HUVECs.
    Mol Med Rep. 2016;14:1553-9.
    PubMed     Text format     Abstract available

    Onco Targets Ther

  20. KONG DB, Chen F, Sima N
    Focal adhesion kinases crucially regulate TGFbeta-induced migration and invasion of bladder cancer cells via Src kinase and E-cadherin.
    Onco Targets Ther. 2017;10:1783-1792.
    PubMed     Text format     Abstract available


  21. DU L, Jiang X, Duan W, Wang R, et al
    Cell-free microRNA expression signatures in urine serve as novel noninvasive biomarkers for diagnosis and recurrence prediction of bladder cancer.
    Oncotarget. 2017 Mar 28. doi: 10.18632/oncotarget.16586.
    PubMed     Text format     Abstract available

  22. KIM YJ, Byun SJ, Ahn H, Kim CS, et al
    Comparison of outcomes between trimodal therapy and radical cystectomy in muscle-invasive bladder cancer: a propensity score matching analysis.
    Oncotarget. 2017 Mar 25. doi: 10.18632/oncotarget.16576.
    PubMed     Text format     Abstract available

  23. MINAMI K, Taniguchi K, Sugito N, Kuranaga Y, et al
    MiR-145 negatively regulates Warburg effect by silencing KLF4 and PTBP1 in bladder cancer cells.
    Oncotarget. 2017 Mar 23. doi: 10.18632/oncotarget.16524.
    PubMed     Text format     Abstract available


  24. LEIVO MZ, Elson PJ, Tacha DE, Delahunt B, et al
    A combination of p40, GATA-3 and uroplakin II shows utility in the diagnosis and prognosis of muscle-invasive urothelial carcinoma.
    Pathology. 2016;48:543-9.
    PubMed     Text format     Abstract available

    PLoS One

  25. XIE JY, Chen PC, Zhang JL, Gao ZS, et al
    The prognostic significance of DAPK1 in bladder cancer.
    PLoS One. 2017;12:e0175290.
    PubMed     Text format     Abstract available

  26. ORRE M, Latorzeff I, Flechon A, Roubaud G, et al
    Adjuvant radiotherapy after radical cystectomy for muscle-invasive bladder cancer: A retrospective multicenter study.
    PLoS One. 2017;12:e0174978.
    PubMed     Text format     Abstract available

    Radiat Oncol

  27. JIANG H, Hu X, Zhang H, Li W, et al
    Down-regulation of LncRNA TUG1 enhances radiosensitivity in bladder cancer via suppressing HMGB1 expression.
    Radiat Oncol. 2017;12:65.
    PubMed     Text format     Abstract available

    Sci Rep

  28. WANG X, Zhang F, Wu XR
    Inhibition of Pyruvate Kinase M2 Markedly Reduces Chemoresistance of Advanced Bladder Cancer to Cisplatin.
    Sci Rep. 2017;7:45983.
    PubMed     Text format     Abstract available

  29. TAN G, Wang H, Yuan J, Qin W, et al
    Three serum metabolite signatures for diagnosing low-grade and high-grade bladder cancer.
    Sci Rep. 2017;7:46176.
    PubMed     Text format     Abstract available

    Tumour Biol

  30. KUMARI N, Agrawal U, Mishra AK, Kumar A, et al
    Predictive role of serum and urinary cytokines in invasion and recurrence of bladder cancer.
    Tumour Biol. 2017;39:1010428317697552.
    PubMed     Text format     Abstract available

  31. EISSA S, Matboli M, Awad N, Kotb Y, et al
    Identification and validation of a novel autophagy gene expression signature for human bladder cancer patients.
    Tumour Biol. 2017;39:1010428317698360.
    PubMed     Text format     Abstract available

    Urol Int

  32. BALCI M, Tuncel A, Keten T, Guzel O, et al
    Comparison of Monopolar and Bipolar Transurethral Resection of Non-Muscle Invasive Bladder Cancer.
    Urol Int. 2017 Apr 6. doi: 10.1159/000467397.
    PubMed     Text format     Abstract available


  33. KLAASSEN Z, Soloway MS
    EAU and AUA/SUO Guidelines on Risk Categories for Non-Muscle Invasive Bladder Cancer May Lead to Overtreatment for Low Grade Ta Bladder Tumors.
    Urology. 2017 Mar 30. pii: S0090-4295(17)30297.
    PubMed     Text format    

    Yakugaku Zasshi

    Development of a Drug Delivery System for Cancer Immunotherapy.
    Yakugaku Zasshi. 2016;136:1477-1484.
    PubMed     Text format     Abstract available

Thank you for your interest in scientific medicine.

AMEDEO Bladder Cancer is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.